AVITA Medical, Inc.
RCEL
$4.62
$0.225.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -4.30% | -12.71% | 21.21% | 66.73% | 29.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.30% | -12.71% | 21.21% | 66.73% | 29.67% |
| Cost of Revenue | 44.91% | -0.09% | 64.33% | 87.24% | 26.95% |
| Gross Profit | -11.26% | -15.17% | 14.25% | 63.50% | 30.06% |
| SG&A Expenses | -10.38% | -22.05% | -11.93% | -1.75% | 18.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.20% | -21.40% | -4.07% | 7.17% | 7.16% |
| Operating Income | -4.53% | 33.70% | 28.65% | 31.26% | 18.87% |
| Income Before Tax | -0.59% | 18.86% | 35.44% | 25.64% | -64.04% |
| Income Tax Expenses | -189.47% | 153.57% | -87.88% | -73.33% | 58.33% |
| Earnings from Continuing Operations | -0.28% | 18.62% | 35.56% | 25.72% | -64.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.28% | 18.62% | 35.56% | 25.72% | -64.03% |
| EBIT | -4.53% | 33.70% | 28.65% | 31.26% | 18.87% |
| EBITDA | -2.23% | 36.43% | 31.28% | 33.51% | 21.00% |
| EPS Basic | 13.70% | 25.54% | 37.04% | 27.47% | -59.83% |
| Normalized Basic EPS | 18.60% | 26.28% | 39.92% | 27.39% | 16.69% |
| EPS Diluted | 13.70% | 25.54% | 37.04% | 27.47% | -59.83% |
| Normalized Diluted EPS | 18.60% | 26.28% | 39.92% | 27.39% | 16.69% |
| Average Basic Shares Outstanding | 16.21% | 9.27% | 2.36% | 2.40% | 2.62% |
| Average Diluted Shares Outstanding | 16.21% | 9.27% | 2.36% | 2.40% | 2.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |